Thinning hair is an age-old concern for both men and women, but Millennials and Gen Z around the world seem to be losing ...

September is supposed to be Wall Street’s notorious villain, rattling the stock market and driving investors to panic — but this year, it eschewed the role. Instead, the S&P 500 SPX and the Nasdaq ...

Dick Cheney called hunting accident 'one of the worst' days of his life Sam Bankman-Fried, serving 25-year sentence, faces a ...

ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis ...

Trybello has enhanced its Bello Hair Helper Spray, which now features a strengthened botanical blend designed to deliver visibly thicker, ...

Bittam offers up to 200x leverage with a zero-slippage index trading system , ensuring every order executes precisely at your ...

Ukrainian President Volodymyr Zelensky has confirmed the first combat use of Ukraine’s homegrown “Flamingo” and “Ruta” missiles, marking a major step in Kyiv’s bid for self-reliant defense amid ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

U.S. stocks closed higher Friday, with the S&P 500 notching a new all-time high after investors got a fresh reading on inflation that was slightly softer than Wall Street expected. The Dow Jones ...

The Dow Jones Industrial Average closed north of 47,000 for the first time on Friday after Wall Street finally got a taste of government data. The blue-chip index rose 472 points, or 1%. The S&P 500 ...

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration. SNDX shares are retreating from ...

(RTTNews) - Johnson & Johnson (JNJ) released new 52-week Phase 3 results from the ICONIC-TOTAL study evaluating icotrokinra, a first-in-class oral peptide that selectively blocks the IL-23 receptor in ...